Welcome to our dedicated page for Beneficient news (Ticker: BENF), a resource for investors and traders seeking the latest updates and insights on Beneficient stock.
Beneficient reports developments tied to its technology-enabled financial services platform for holders of alternative assets. The company provides exit opportunities, primary capital solutions, and related trust and custody services, with activity centered on customized trust vehicles, limited partner interests, and a loan portfolio collateralized by alternative asset investments.
Recurring BENF news covers operating and financial results, cost management, operational efficiency, debt repayment, asset sales, equity redemptions, preferred-stock issuances, material agreements, shareholder voting matters, and governance updates. Company updates also address its capital structure, including Class A common stock, convertible preferred stock, and warrants.
Beneficient (Nasdaq: BENF) highlighted its role in supporting rural Kansas after 15 communities received a combined $337,833 in SEED grants on Dec. 22, 2025 to fund strategic economic expansion and quality-of-life projects.
The SEED awards, funded by proceeds from assets financed under the Kansas TEFFI Act (for which a Beneficient subsidiary holds the state’s first TEFFI charter), plus local matches, generate almost $1.1 million in total 2025 investment. Since 2021, more than $3.5 million has been distributed to Kansas communities through SEED grants linked to Beneficient’s TEFFI operations.
Awards required at least a 10% local match and project completion within 12 months.
Beneficient (NASDAQ: BENF) closed a ~$3.0 million GP primary capital transaction with Cork & Vines Fund I, LP on January 8, 2026. The Fund received approximately $3 million in stated value of Beneficient Resettable Convertible Preferred Stock, which the holder may convert into Class A common stock under the transaction terms.
The deal follows an initial GP Primary Capital transaction with Cork & Vines that closed in early 2025 and is expected to increase collateral for Beneficient’s ExAlt loan portfolio by ~ $3.0 million of interests in alternative assets. The transaction expands Beneficient’s GP Primary Commitment Program, which provides primary capital solutions and anchor commitments to general partners and targets a potential demand pool of up to $330 billion for primary commitments.
Beneficient (Nasdaq: BENF) announced that, by letter dated January 2, 2026, Nasdaq notified the company it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) and the continued listing requirements for warrants under Nasdaq Listing Rule 5560(a).
As a result, Beneficient is now in full compliance with The Nasdaq Capital Market’s listing requirements.
Beneficient (NASDAQ: BENF) appointed Peter T. Cangany Jr. as Chairman of the Board, effective December 15, 2025.
Mr. Cangany has served as a Beneficient director and as Chairman of the independent Audit Committee since 2019. He retired as a partner from Ernst & Young in 2017 after nearly 40 years, with more than two decades as a partner, and brings decades of financial reporting, accounting, and corporate governance experience in financial services. He is a Certified Public Accountant with a B.A. in Accounting from Franklin College and an M.B.A. from Texas A&M University.
Beneficient (Nasdaq: BENF) announced a 1-for-8 reverse stock split of its Class A and Class B common stock, effective so shares will trade on a split-adjusted basis when markets open on December 15, 2025. The reverse split was approved by stockholders on December 1, 2025, and will change the CUSIP to 08178Q507. The action is intended to enable Beneficient to regain compliance with Nasdaq's minimum bid price requirement. Every eight pre-split shares will be combined into one post-split share, authorized shares of Class A and Class B will be proportionally reduced, and outstanding equity awards, warrants and convertible preferred stock will be adjusted with higher exercise or conversion prices.
Registered holders in book-entry form need not act; broker-held positions will be adjusted per each broker's process.
Beneficient (NASDAQ: BENF) announced the passing of Thomas O. Hicks, Chairman of the Board, who died on December 6, 2025 at age 79. Mr. Hicks co-founded Hicks & Haas (1984) and Hicks, Muse, Tate & Furst (1989) and was described as a private equity pioneer with a “buy and build” strategy.
He served on Beneficient’s Board since 2017 and was appointed Chairman in July 2025. The company said its Board and management will honor his legacy and continue executing the Company’s mission. The announcement extends condolences to Mr. Hicks’ family and notes an obituary is available.
Beneficient (NASDAQ: BENF) reported fiscal Q2 2026 results for the quarter ended September 30, 2025, highlighting cost reductions, capital-structure moves and improved Nasdaq compliance. Key metrics: investments at fair value $244.0M, Ben Liquidity loan portfolio net $223.1M (gross loans $581M; allowance $358M), cash $4.9M and total debt $104.0M. Operating expenses declined 38.8% excluding certain non-cash items to $13.4M in Q2. Year-to-date asset sales and redemptions generated $46.4M gross proceeds used for debt paydown and working capital. On October 15, 2025, $52.6M of BCH Preferred A-1 held by leadership was converted into Class A common stock, and on October 29, 2025 Nasdaq compliance was regained.
Summary not available.
Beneficient (NASDAQ: BENF) announced that Nasdaq notified the company on October 29, 2025 that it has regained compliance with two listing standards: (i) the Nasdaq periodic reporting requirement after filing its Form 10-K for fiscal year ended March 31, 2025 and Form 10-Q for quarter ended June 30, 2025, and (ii) the $35 million market value of listed securities requirement as an alternative to the minimum stockholders’ equity test.
The company remains noncompliant with the $1.00 per share bid price requirement and must regain compliance within the extension period granted by the Nasdaq Hearings Panel. If compliance is not achieved, the company plans to seek stockholder approval for a reverse stock split intended to restore the $1.00 bid price for the required 10-consecutive trading day period.
Beneficient (NASDAQ: BENF) announced a Limited Conversion where Chairman Thomas O. Hicks and Interim CEO James G. Silk converted approximately $48.0M and $4.6M of Preferred A-1 units of subsidiary BCH into 92,485,639 and 8,808,649 shares of Class A common stock, respectively.
The conversion follows a Nasdaq notice on October 3, 2025 regarding noncompliance with the minimum stockholders’ equity requirement and is intended to support compliance with the MVLS $35M alternative. The Conversion Shares are subject to a voting and lock-up until October 1, 2028, and Messrs. Hicks and Silk agreed to forfeit any appreciation in value of the Conversion Shares at lock-up expiration.